Refine by
Mrna Articles & Analysis
96 news found
Utilizing system biology approaches, adjuvant, mRNA, and vector-based technologies, Protheragen provides mRNA vaccine, DNA vaccine, live-attenuated vaccine, virus-like particle vaccine, protein subunit vaccine, and many other custom vaccines. ...
They are essential for the efficient transportation of mRNA to target cells, ensuring that therapeutic mRNA is delivered to the cytoplasm, where it can effectively produce the target protein. This process is crucial for the success of mRNA vaccines. Major pharmaceutical companies are increasingly incorporating LNP technology into their clinical ...
This formulation can be used to develop mRNA cancer vaccines without modification of any active targeting ligand. ...
BOC Sciences' exosome delivery systems are engineered to deal with every type of nucleic acid, with the following conventional nucleic acid types now available: siRNA, mRNA, miRNA, circRNA, lncRNA, DNA, Aptamer, ASO, etc. If there are any specific or unique requirements, BOC Sciences has a professional technical team to provide swift and tailored solutions. ...
N6-methyladenosine (m6A), the most prevalent modification in messenger RNA, plays a crucial role in mRNA fate. CD Genomics, a leader in genomics and sequencing services, is proud to introduce MeRIP sequencing, a state-of-the-art technology that offers a comprehensive analysis of m6A locations in RNA transcripts. ...
BOC Sciences invites attendees to join them at booth #937 for a robust discussion around their progress and challenges in oligonucleotide, mRNA, or peptide development. How can the biotech company aid in the continued development of these exciting fields? ...
The iGEM (International Genetically Engineered Machine) Competition is an annual event in synthetic biology. Teams participating in iGEM typically spend several months conducting research, designing their projects, and building their biological systems. These projects can range from addressing real-world problems in areas such as healthcare, environmental sustainability, and manufacturing, to ...
By introducing bacteriophage SP6 into the transcriptional promoter and a completely artificial E01 sequence selected from a randomized nucleic acid sequence pool into the translational enhancer, an mRNA with high translational activity can be produced, and protein synthesis efficiency can be maximized. ...
(ALM), a global pharmaceutical company focused on medical dermatology, and etherna, an mRNA/LNP technology platform company, announced today a multi-target alliance to discover and develop new mRNA-based therapies for severe skin diseases, including non-melanoma skin cancer. ...
ByeTheRNA
Their pioneering research has revolutionized the way we combat infectious diseases and has undoubtedly saved countless lives during the COVID-19 pandemic." In effect, mRNA vaccines have reached the spotlight for a while as a new alternative to conventional vaccines. The scientific community still faces hurdles, though, when it comes to efficient and safe delivery of ...
Alfa Chemistry, a renowned scientific research service provider, has established itself as a leading player in the field of mRNA vaccine solutions, employing an integrated approach to excel in every aspect of vaccine development, production, optimization, and quality control. mRNA Vaccine Development To begin with, Alfa Chemistry's commitment to ...
The simplicity and efficiency of this kit make it an ideal choice for gene expression (mRNA) analysis, copy number analysis, and SNP genotype analysis. The kit is shipped with dry ice and gel packs, and is stable for up to 1 year at -20 degrees Celsius. ...
etherna (“the Company”), a leading mRNA/LNP technologies company, announced today that Bernard Sagaert has been confirmed-as Chief Executive Officer. ...
ByeTheRNA
About bYoRNA SAS bYoRNA SAS is a French biotechnology company focused on developing a cost-efficient and scalable mRNA bioproduction platform for prophylactic and oncological vaccines. mRNA is currently produced in vitro via enzymatic synthesis, an expensive method. ...
These chemicals have inclusive applications in mRNA vaccines and therapeutics, RNA therapeutics (ASO, siRNA, miRNA, Aptamer), nucleic acid detection, gene sequencing and editing (CRISPR-Cas9), and oligonucleotide synthesis, etc. ...
Enhanced amplification of these targets ensures high cDNA yields from all RNA, including total RNA, mRNA, snRNA, and viral RNA. Since the 1Step RT PCR Kit adopts the one-step method to enable RT and PCR to be carried out in the same reaction system, no reagent needs to be added and the tube cover does not need to be opened in the reaction process, thus avoiding ...
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, recently introduced a line of highly efficient mRNA Transfection Reagents with low toxicity for research applications, including the mRNA Transfection Reagent, Stem mRNA Transfection Reagent, and mRNA/gRNA Transfection Reagent. ...
The featured vaccine products supplied by Alfa Chemistry are listed as below: Nucleic Acid Delivery ExcipientsNucleotide vaccines, including mRNA vaccines with their intracellular antigen synthesis, have been shown to be potent activators of a cytotoxic immune response. However, the intracellular delivery of mRNA vaccines to the cytosol of antigen presenting ...
Quantoom Biosciences, a Univercells’ company, is leading the development of the mRNA production technology that encompasses all the steps of RNA production, from sequence construct to large scale production, allowing for rapid growth and scale-up. ...
ByeTheRNA
This platform uses an innovative vector approach to pack split genes into individual vgAAV vectors and generate a full-length protein via mRNA trans-splicing. ViGeneron is a spin-off of the Ludwig-Maximilians-University (LMU) in Munich. ...